Journal article
Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities
The Journal of nuclear medicine (1978), Vol.62(Suppl 3), pp.48S-59S
12/2021
DOI: 10.2967/jnumed.121.262752
PMID: 34857622
Abstract
Interest in performing dosimetry for clinical radiopharmaceutical therapy procedures has grown in recent years. Several approved therapies include dosimetry in the Food and Drug Administration-approved label instructions, and other therapies are best used under a patient-tailored paradigm. This paper, which is a product of the Society of Nuclear Medicine and Molecular Imaging Dosimetry Task Force, presents motivations and general workflows for radiopharmaceutical therapy dosimetry, as well as existing strategies for obtaining reimbursement for clinical activities related to dosimetry. Several specific patient examples are provided, including suggested codes for reimbursement. In addition to current reimbursement approaches, key dosimetry services that are not supported under the current coding structure are presented and suggested as areas of focus in the coming years.
Details
- Title: Subtitle
- Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities
- Creators
- Stephen A Graves - University of IowaAlexandru Bageac - Radiology AssociatesJames R CrowleyDenise A M Merlino - Merlino Healthcare Consulting Corp., Magnolia, Massachusetts.
- Resource Type
- Journal article
- Publication Details
- The Journal of nuclear medicine (1978), Vol.62(Suppl 3), pp.48S-59S
- DOI
- 10.2967/jnumed.121.262752
- PMID
- 34857622
- ISSN
- 1535-5667
- eISSN
- 1535-5667
- Language
- English
- Date published
- 12/2021
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Radiology; Radiation Oncology
- Record Identifier
- 9984383302302771
Metrics
71 Record Views